Cargando…
Biotechnology in China – regulation, investment, and delayed commercialization
China has been investing heavily in biotechnology to increase agricultural productivity. While a number of Chinese developed GM crops have cleared the required scientific hurdles – some more than a decade ago – commercialization has not been approved. The regulatory regime for GMOs in China is relat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090284/ https://www.ncbi.nlm.nih.gov/pubmed/35506348 http://dx.doi.org/10.1080/21645698.2022.2068336 |